Drugs / 5-FLUORONICOTINIC ACID
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00169182 Background | Dec 2001 → Apr 2009 | hypopharyngeal carcinoma, larynx cancer | Groupe Oncologie Radiotherapie Tete et Cou | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5-FLUORONICOTINIC ACID | ChEMBL registry synonym — accepted as the source's own label CHEMBL397783 ↗ |
| Known as | 5-Fluoro-3-Pyridinecarboxylic Acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00169182 ↗ |
| Modality | Small molecule | — CHEMBL397783 ↗ |
| Route | Other | “750 mg/m 2 by 24-hour continuous infusion for 5 days” NCT00169182 ↗ |